On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics hasd entered into a…
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) received notice that its SARS-CoV-2 qPCR Kit had complied with…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements,…
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaﾮ molecular assay to detect…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
On Apr. 23, 2020, BioSig Technologies announced that an article titled, ‘The IMPDH inhibitor merimepodib has similar antiviral…
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
On Apr. 22, 2020, Quidel announced it has applied for an Emergency Use Authorization (EUA) for the Lyraﾮ…
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…